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Cartilage volume measurements were assessed by Magnetic Resonance
Imaging (MRI) at preoperative period and 1 year after operation.
Results: All patients completed 1 year of study period. After the surgery, all
subscales of WOMAC scores in both groups were signiﬁcantly improved
(p<0.001) when compare to baseline levels. However, there were no
differences between the two groups. Patients who received intra-articular
hyaluronic acid injections had signiﬁcantly reduce the amount of diclofe-
nac consumption (p¼0.017). MRI studies showed signiﬁcantly increase of
the total cartilage volume (p¼0.033), lateral femoral volume (p¼0.044)
and lateral tibial volume (p¼0.027) in the study group compared to the
control group. In addition, loss of lateral tibial plateau cartilage volume
was showed only in the control group. There were no severe adverse
events in both groups.
Conclusion: This study demonstrated positive synergistic effect for using
continuous intra-articular hyaluronic acid injection in patients with oste-
oarthritis of the knee who underwent high tibial osteotomy. Base on our
ﬁnding, intra-articular hyaluronic acid may beneﬁcial to increased total
cartilage volume and prevented the loss of cartilage at lateral tibiofemoral
joint after high tibial osteotomy. Further long term studies with larger
number of patients are warranted.
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Purpose: Recently, anti-cytokine therapy has gainedmomentum as a long-
term treatment solution for osteoarthritis (OA). While a good deal of work
has been done to characterize the cytokine proﬁles of whole blood and
autologous protein solution (APS) from healthy donors, there is very little
literature proﬁling the peripheral blood of OA patients. By performing
cytokine and growth factor analysis on the whole blood and APS of OA
patients, we hope to discover important cytokine interactions as well as
determine the compatibility of an autologous anti-cytokine therapeutic
within an OA patient population. The interactions of cytokines and growth
factors have been analyzed from 60 samples collected thus far in an
ongoing, 105 patient study.
Methods: OA patients were enrolled from 4 sites. From each patient, 60 ml
of blood and a baseline sample were collected. The 60 ml sample was
processed via centrifugation and desiccation to produce APS. The baseline
and APS samples were either shipped in dry ice or personally delivered to
the Biomet Biologics facility where they were frozen at -50C. ELISA was
used to measure the concentration of 13 cytokines and growth factors
(Quantikine kits, R&D Systems). Average concentrations were compared to
published data from healthy donors. Spearman's r correlation was used to
determine signiﬁcant correlation between cytokines. Demographic data
and a KOOS survey was also collected from the patients, and body mass
index (BMI), overall KOOS score, age, and APS volumewere included in the
correlation analysis as well.
Results: Although the growth factor concentrations were lower in the
baseline blood and APS of OA patients, the anti-inﬂammatory cytokine
concentrations were at least as high as those seen from healthy donors
(Fig. 1).
A comparison of baseline and APS cytokine levels revealed some inter-
esting correlation patterns (Fig. 2). EGF, PDGF-AB, PDGF-BB, and TGF-b1
exhibited positive correlationwith each other in both the baseline and APS
samples. This indicates that those four growth factors act in concert and
probably share some of the same pathways. As one might expect, sTNF-RI
and sTNF-RII exhibit a very strong positive correlation, and the APS of both
of these cytokines correlate with TNFa as well. KOOS score exhibited
negative correlation with the baseline concentration of PDGF-AB and TGF-
b1, indicating that patients with higher concentrations of those growth
factors in their peripheral blood responded more positively on the KOOS
survey. BMI exhibited a positive correlation with baseline and APSconcentrations of IL-6, as well as with the APS concentration of sTNF-RI
and sTNF-RII. A positive correlation of IL-6 concentration with BMI reveals
that patients who are more obese are more likely to have a higher
concentration of IL-6 in their circulating blood. This reinforces the
currently held theory that obesity is an inﬂammatory condition.ĂConclusions: In conclusion, there is much that can be learned from the
cytokine and growth factor concentrations of OA patients. The addition of
more patients to this study will lead to even more conclusive evidence of
the various cytokine and growth factor interactions that appear to be
taking place. Additional samples may validate the results obtained to date.
If the current results are conﬁrmed, this data will strengthen the case for
APS as an anti-cytokine therapy and warrant further research of APS for
the treatment of OA.
